Achromatopsia (ACHM) is a hereditary cone photoreceptor disorder characterized by the inability to discriminate colors, nystagmus, photophobia, and low‐visual acuity. Six genes have been associated with this rare autosomal recessively inherited disease, including the GNAT2 gene encoding the catalytic α‐subunit of the G‐protein transducin which is expressed in the cone photoreceptor outer segment. Out of a cohort of 1,116 independent families diagnosed with a primary clinical diagnosis of ACHM, we identified 23 patients with ACHM from 19 independent families with likely causative mutations in GNAT2, representing 1.7% of our large ACHM cohort. In total 22 different potentially diseasecausing variants, of which 12 are novel, were identified. The mutation spectrum also includes a novel copy number variation, a heterozygous duplication of exon 4, of which the breakpoint matches exactly that of the previously reported exon 4 deletion. Two patients carry just a single heterozygous variant. In addition to our previous study on GNAT2‐ ACHM, we also present detailed clinical data of these patients.

Felden J, B.B. (2019). Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene. HUMAN MUTATION, 40(8), 1145-1155 [10.1002/humu.23768].

Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene

Vadala M
Investigation
;
2019-01-01

Abstract

Achromatopsia (ACHM) is a hereditary cone photoreceptor disorder characterized by the inability to discriminate colors, nystagmus, photophobia, and low‐visual acuity. Six genes have been associated with this rare autosomal recessively inherited disease, including the GNAT2 gene encoding the catalytic α‐subunit of the G‐protein transducin which is expressed in the cone photoreceptor outer segment. Out of a cohort of 1,116 independent families diagnosed with a primary clinical diagnosis of ACHM, we identified 23 patients with ACHM from 19 independent families with likely causative mutations in GNAT2, representing 1.7% of our large ACHM cohort. In total 22 different potentially diseasecausing variants, of which 12 are novel, were identified. The mutation spectrum also includes a novel copy number variation, a heterozygous duplication of exon 4, of which the breakpoint matches exactly that of the previously reported exon 4 deletion. Two patients carry just a single heterozygous variant. In addition to our previous study on GNAT2‐ ACHM, we also present detailed clinical data of these patients.
2019
Settore MED/30 - Malattie Apparato Visivo
Settore BIO/18 - Genetica
Felden J, B.B. (2019). Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene. HUMAN MUTATION, 40(8), 1145-1155 [10.1002/humu.23768].
File in questo prodotto:
File Dimensione Formato  
Human Mutation 2019.pdf

Solo gestori archvio

Descrizione: articolo
Tipologia: Post-print
Dimensione 946.73 kB
Formato Adobe PDF
946.73 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/362996
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 17
social impact